Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome

Our objectives are to demonstrate whether the kynurenine pathway is activated in diarrhea-type irritable bowel syndrome (IBS-D) patients, and whether the neurotoxic metabolite quinolinic acid (QUIN) is out of balance with the neuroprotective metabolite kynurenic acid (KYNA), and further explore whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pingping, Zheng, Jimin, Bai, Yun, Wang, Dingxin, Cui, Zijin, Li, Yueqin, Zhang, Jian, Wang, Yuzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388639/
https://www.ncbi.nlm.nih.gov/pubmed/32705857
http://dx.doi.org/10.4081/ejh.2020.3132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388639/
https://www.ncbi.nlm.nih.gov/pubmed/32705857
http://dx.doi.org/10.4081/ejh.2020.3132

Ejemplares similares